164 related articles for article (PubMed ID: 20048074)
21. WSB1/2 target chromatin-bound lysine-methylated RelA for proteasomal degradation and NF-κB termination.
Zhang J; Yu Y; Zou X; Du Y; Liang Q; Gong M; He Y; Luo J; Wu D; Jiang X; Sinclair M; Tajkhorshid E; Chen HZ; Hou Z; Zheng Y; Chen LF; Yang XD
Nucleic Acids Res; 2024 May; 52(9):4969-4984. PubMed ID: 38452206
[TBL] [Abstract][Full Text] [Related]
22. A Role for the Autophagic Receptor, SQSTM1/p62, in Trafficking NF-κB/RelA to Nucleolar Aggresomes.
Lobb IT; Morin P; Martin K; Thoms HC; Wills JC; Lleshi X; Olsen KCF; Duncan RR; Stark LA
Mol Cancer Res; 2021 Feb; 19(2):274-287. PubMed ID: 33097627
[TBL] [Abstract][Full Text] [Related]
23. Tumor necrosis factor-alpha induces RelA degradation via ubiquitination at lysine 195 to prevent excessive nuclear factor-kappaB activation.
Fan Y; Mao R; Zhao Y; Yu Y; Sun W; Song P; Shi Z; Zhang D; Yvon E; Zhang H; Fu S; Yang J
J Biol Chem; 2009 Oct; 284(43):29290-7. PubMed ID: 19706600
[TBL] [Abstract][Full Text] [Related]
24. Pim-1 controls NF-kappaB signalling by stabilizing RelA/p65.
Nihira K; Ando Y; Yamaguchi T; Kagami Y; Miki Y; Yoshida K
Cell Death Differ; 2010 Apr; 17(4):689-98. PubMed ID: 19911008
[TBL] [Abstract][Full Text] [Related]
25. FMNL2 destabilises COMMD10 to activate NF-κB pathway in invasion and metastasis of colorectal cancer.
Yang SS; Li XM; Yang M; Ren XL; Hu JL; Zhu XH; Wang FF; Zeng ZC; Li JY; Cheng ZQ; Liao WT; Ding YQ; Guan J; Liang L
Br J Cancer; 2017 Oct; 117(8):1164-1175. PubMed ID: 28817833
[TBL] [Abstract][Full Text] [Related]
26. Constitutive RelA activation mediated by Nkx3.2 controls chondrocyte viability.
Park M; Yong Y; Choi SW; Kim JH; Lee JE; Kim DW
Nat Cell Biol; 2007 Mar; 9(3):287-98. PubMed ID: 17310243
[TBL] [Abstract][Full Text] [Related]
27. Inhibitor of growth 4 induces NFκB/p65 ubiquitin-dependent degradation.
Hou Y; Zhang Z; Xu Q; Wang H; Xu Y; Chen K
Oncogene; 2014 Apr; 33(15):1997-2003. PubMed ID: 23624912
[TBL] [Abstract][Full Text] [Related]
28. The ORF2 glycoprotein of hepatitis E virus inhibits cellular NF-κB activity by blocking ubiquitination mediated proteasomal degradation of IκBα in human hepatoma cells.
Surjit M; Varshney B; Lal SK
BMC Biochem; 2012 May; 13():7. PubMed ID: 22590978
[TBL] [Abstract][Full Text] [Related]
29. Phosphorylation of RelA/p65 on serine 536 defines an I{kappa}B{alpha}-independent NF-{kappa}B pathway.
Sasaki CY; Barberi TJ; Ghosh P; Longo DL
J Biol Chem; 2005 Oct; 280(41):34538-47. PubMed ID: 16105840
[TBL] [Abstract][Full Text] [Related]
30. Protein kinase Cdelta activates RelA/p65 and nuclear factor-kappaB signaling in response to tumor necrosis factor-alpha.
Lu ZG; Liu H; Yamaguchi T; Miki Y; Yoshida K
Cancer Res; 2009 Jul; 69(14):5927-35. PubMed ID: 19549902
[TBL] [Abstract][Full Text] [Related]
31. COMMD1-mediated ubiquitination regulates CFTR trafficking.
Drévillon L; Tanguy G; Hinzpeter A; Arous N; de Becdelièvre A; Aissat A; Tarze A; Goossens M; Fanen P
PLoS One; 2011 Mar; 6(3):e18334. PubMed ID: 21483833
[TBL] [Abstract][Full Text] [Related]
32. The oncoprotein gankyrin interacts with RelA and suppresses NF-kappaB activity.
Higashitsuji H; Higashitsuji H; Liu Y; Masuda T; Fujita T; Abdel-Aziz HI; Kongkham S; Dawson S; John Mayer R; Itoh Y; Sakurai T; Itoh K; Fujita J
Biochem Biophys Res Commun; 2007 Nov; 363(3):879-84. PubMed ID: 17904523
[TBL] [Abstract][Full Text] [Related]
33. PDLIM7 Synergizes With PDLIM2 and p62/Sqstm1 to Inhibit Inflammatory Signaling by Promoting Degradation of the p65 Subunit of NF-κB.
Jodo A; Shibazaki A; Onuma A; Kaisho T; Tanaka T
Front Immunol; 2020; 11():1559. PubMed ID: 32849529
[TBL] [Abstract][Full Text] [Related]
34. Regulation of the MDM2-p53 pathway by the nucleolar protein CSIG in response to nucleolar stress.
Xie N; Ma L; Zhu F; Zhao W; Tian F; Yuan F; Fu J; Huang D; Lv C; Tong T
Sci Rep; 2016 Nov; 6():36171. PubMed ID: 27811966
[TBL] [Abstract][Full Text] [Related]
35. Tumor suppressor ARF promotes non-classic proteasome-independent polyubiquitination of COMMD1.
Huang Y; Wu M; Li HY
J Biol Chem; 2008 Apr; 283(17):11453-60. PubMed ID: 18305112
[TBL] [Abstract][Full Text] [Related]
36. Proteasome inhibitors induce nucleolar aggregation of proteasome target proteins and polyadenylated RNA by altering ubiquitin availability.
Latonen L; Moore HM; Bai B; Jäämaa S; Laiho M
Oncogene; 2011 Feb; 30(7):790-805. PubMed ID: 20956947
[TBL] [Abstract][Full Text] [Related]
37. NF-kappaB regulates the stability and activity of p73 by inducing its proteolytic degradation through a ubiquitin-dependent proteasome pathway.
Kikuchi H; Ozaki T; Furuya K; Hanamoto T; Nakanishi M; Yamamoto H; Yoshida K; Todo S; Nakagawara A
Oncogene; 2006 Dec; 25(58):7608-17. PubMed ID: 16953234
[TBL] [Abstract][Full Text] [Related]
38. COMMD1 Promotes pVHL and O2-Independent Proteolysis of HIF-1alpha via HSP90/70.
van de Sluis B; Groot AJ; Vermeulen J; van der Wall E; van Diest PJ; Wijmenga C; Klomp LW; Vooijs M
PLoS One; 2009 Oct; 4(10):e7332. PubMed ID: 19802386
[TBL] [Abstract][Full Text] [Related]
39. A novel NF-kappaB pathway involving IKKbeta and p65/RelA Ser-536 phosphorylation results in p53 Inhibition in the absence of NF-kappaB transcriptional activity.
Jeong SJ; Pise-Masison CA; Radonovich MF; Park HU; Brady JN
J Biol Chem; 2005 Mar; 280(11):10326-32. PubMed ID: 15611068
[TBL] [Abstract][Full Text] [Related]
40. Fas-associated factor-1 inhibits nuclear factor-kappaB (NF-kappaB) activity by interfering with nuclear translocation of the RelA (p65) subunit of NF-kappaB.
Park MY; Jang HD; Lee SY; Lee KJ; Kim E
J Biol Chem; 2004 Jan; 279(4):2544-9. PubMed ID: 14600157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
